Vicore Pharma Holding AB (publ) Financial Flexibility Index
Vicore Pharma Holding AB (publ) financial flexibility index. Vicore Pharma Holding AB (publ) (VICO) has a Financial Flexibility Index of 0.00x as of December 2025. Free cash flow of Skr0.00 (operating CF Skr-81.48 Million minus capex Skr81.48 Million) represents 0% of total liabilities (Skr124.16 Million). See VICO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Vicore Pharma Holding AB (publ) (2012–2025)
Financial flexibility index of Vicore Pharma Holding AB (publ) from 2012 to 2025. Historical Financial Flexibility Index trend for Vicore Pharma Holding AB (publ) across 14 annual periods. Check Vicore Pharma Holding AB (publ) cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Vicore Pharma Holding AB (publ) Financial Flexibility Index by Year (2012–2025)
Vicore Pharma Holding AB (publ) financial flexibility index by year from 2012 to 2025. Year-by-year free cash flow to debt coverage for Vicore Pharma Holding AB (publ). For the full cash flow conversion analysis, see VICO cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (SEK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | Skr0.00 | Skr-374.44 Million | Skr124.16 Million | ▲ +100.0% |
| 2024 | -1.36x | Skr-100.14 Million | Skr-164.95 Million | Skr73.78 Million | ▼ -14.0% |
| 2023 | -1.19x | Skr-50.54 Million | Skr-249.58 Million | Skr42.45 Million | ▲ +80.4% |
| 2022 | -6.07x | Skr-296.92 Million | Skr-299.92 Million | Skr48.92 Million | ▼ -55.3% |
| 2021 | -3.91x | Skr-265.17 Million | Skr-265.17 Million | Skr67.85 Million | ▼ -73.8% |
| 2020 | -2.25x | Skr-116.94 Million | Skr-119.94 Million | Skr52.00 Million | ▲ +49.5% |
| 2019 | -4.45x | Skr-86.85 Million | Skr-87.00 Million | Skr19.51 Million | ▼ -131.8% |
| 2018 | -1.92x | Skr-31.04 Million | Skr-33.04 Million | Skr16.16 Million | ▼ -200.5% |
| 2017 | 1.91x | Skr12.53 Million | Skr-7.71 Million | Skr6.56 Million | ▲ +85.7% |
| 2016 | 1.03x | Skr6.23 Million | Skr-7.25 Million | Skr6.05 Million | ▲ +279.9% |
| 2015 | 0.27x | Skr1.98 Million | Skr-3.68 Million | Skr7.29 Million | ▼ -77.0% |
| 2014 | 1.18x | Skr6.67 Million | Skr-2.83 Million | Skr5.67 Million | ▲ +819.0% |
| 2013 | -0.16x | Skr-1.79 Million | Skr-1.79 Million | Skr10.97 Million | ▼ -20.6% |
| 2012 | -0.14x | Skr-1.64K | Skr-1.67K | Skr12.09K | — |